Could a palm extract help fight a rare genetic brain disease?
NCT ID NCT04658823
First seen Feb 02, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This study tested a palm-derived supplement (HOV-12020) in 50 adults aged 45-75 with CADASIL, a rare genetic disease that damages small blood vessels in the brain, leading to strokes and memory loss. The goal was to see if the supplement could reduce worsening of symptoms like stroke, disability, or cognitive decline over 24 months. Results are not yet available, but the supplement was previously shown to help similar blood vessel damage in other conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CADASIL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Lariboisière APHP
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.